Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / EOLS - Evolus attracts buy rating from Needham at $18 price target

EOLS - Evolus attracts buy rating from Needham at $18 price target

Evolus Inc.
Evolus (NASDAQ:EOLS) shares are up 5.3% in early trading on Wednesday after Needham started off coverage on this medical aesthetic company with a Buy Rating. Analyst Serge Belanger has set a price target of $18 on Evolus, citing it as a "aesthetics emerging star." That implies a potential upside of 56% on stock's last close. Wall Street analysts, on an average, give a Strong Buy rating with a average price target of $16.14 while Seeking Alpha Quant rating is at Hold. Take a quick look through Quant's factor grades: Earlier: Evolus stock rises as Q1 revenue soars 177% Y/Y

For further details see:

Evolus attracts buy rating from Needham at $18 price target
Stock Information
Company Name: Evolus Inc.
Stock Symbol: EOLS
Market: NASDAQ
Website: evolus.com
Menu
EOLS EOLS Quote EOLS Short EOLS News EOLS Articles EOLS Message Board
Get EOLS Alerts

News, Short Squeeze, Breakout and More Instantly...